Troy
Analyst
Leerink Partners
Equibles does not estimate personal net worth.
About Troy
Troy is recorded as Analyst at Leerink Partners. Troy has spoken on 1 earnings call across 1 company, most recently for Relmada Therapeutics, Inc. on November 12, 2026. The companies whose calls Troy spoke on are classified in the Healthcare sector.
Troy on recent calls
“With the IND filing expected by year-end, how quickly do you think you can get from IND clearance to first patient dosed? Thanks.”
Affiliation history
-
Leerink Partners
Analyst
Transcript header (unverified)
Current